Robert F. Anderson

Maimonides Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

41h-index4.7kcitations212works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(39), Free Radicals and Antioxidants(28), Photochemistry and Electron Transfer Studies(19), Electron Spin Resonance Studies(19), DNA and Nucleic Acid Chemistry(16)

Publications212 total

Correction: Anderson, R.F.; Qi, W. Coenzyme Q10 as an Inhibitor of Effector Release from One-Electron-Reduced Bioreductive Anticancer Prodrugs. Molecules 2025, 30, 760
Molecules·2025Open Access
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
Nature Genetics·2025Open Access
Dioxygenation of tryptophan residues by superoxide and myeloperoxidase
Journal of Biological Chemistry·2025Open Access
Coenzyme Q10 as an Inhibitor of Effector Release from One-Electron-Reduced Bioreductive Anticancer Prodrugs
Molecules·2025· 1 citedOpen Access
Chain-release of quinoline-based drugs from <i>N</i>-alkoxyquinoline prodrugs upon radiolytic one-electron reduction
Chemical Communications·2025· 1 cited
Redox factors in the antioxidant activity of nitroxides toward DNA guanyl and 2-deoxyribose-peroxyl radicals
Free Radical Research·2024Open Access
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
Nature Genetics·2024· 58 citedOpen Access
Masking the Bioactivity of Hydroxamic Acids by Coordination to Cobalt: Towards Bioreductive Anticancer Agents
Chemistry - A European Journal·2024· 1 citedOpen Access
Chemical Repair of Radical Damage to the GC Base Pair by DNA-Bound Bisbenzimidazoles
The Journal of Physical Chemistry B·2024Open Access
Hypoxia-activated prodrugs of phenolic olaparib analogues for tumour-selective chemosensitisation
RSC Medicinal Chemistry·2023· 4 citedOpen Access
Spin Trapping Hydroxyl and Aryl Radicals of One-Electron Reduced Anticancer Benzotriazine 1,4-Dioxides
Molecules·2022· 6 citedOpen Access
Selectively Targeting Tumor Hypoxia with the Hypoxia-Activated Prodrug CP-506
2021· 4 citedOpen Access
OC-0562: Exploiting tumor DNA repair status and hypoxia with CP-506, a novel hypoxia-activated prodrug
Radiotherapy and Oncology·2020
Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity
Molecules·2020· 6 citedOpen Access
Intra-dimer cooperativity between the active site cysteines during the oxidation of peroxiredoxin 2
Free Radical Biology and Medicine·2020· 18 citedOpen Access
Intra-dimer cooperativity between the active site cysteines during the oxidation of peroxiredoxin 2
2020· 1 citedOpen Access
The reduction potential of the slipped GC base pair in one-electron oxidized duplex DNA
Physical Chemistry Chemical Physics·2019· 3 cited
Engineering <i>Escherichia coli</i> NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug Therapy
Biochemistry·2019· 14 cited
Integrator for Nanosecond Pulses
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2019Open Access
Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors
Molecules·2019· 4 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

William A. Denny(14), S.S. Shinde(11), Michael P. Hay(10), William R. Wilson(10), Andrej Maroz(6), Frederik B. Pruijn(6), Adam V. Patterson(4), Russ Hille(4), Swarna A. Gamage(3), Kevin O. Hicks(3), David I. Pattison(3), Michael J. Davies(3), John S. Stehlin(3), Peter D. de Ipolyi(3), Beppino C. Giovanella(3), William Wilson(3), Moana Tercel(3), Tracy A. Prime(2), Angela Logan(2), Andrew M. James(2)